0000950123-23-001984.txt : 20230213 0000950123-23-001984.hdr.sgml : 20230213 20230213161020 ACCESSION NUMBER: 0000950123-23-001984 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 EFFECTIVENESS DATE: 20230213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Column Group LLC CENTRAL INDEX KEY: 0001833486 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20797 FILM NUMBER: 23618489 BUSINESS ADDRESS: STREET 1: 1 LETTERMAN DRIVE, BUILDING D STREET 2: SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: 1 LETTERMAN DRIVE, BUILDING D STREET 2: SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001833486 XXXXXXXX 12-31-2022 12-31-2022 false Column Group LLC
1 Letterman Drive, Building D Suite M-900 San Francisco CA 94129
13F HOLDINGS REPORT 028-20797 N
James Evangelista Chief Financial Officer (415) 865-2050 /s/ James Evangelista San Francisco CA 02-13-2023 0 7 300399162 false
INFORMATION TABLE 2 20415.xml INFORMATION TABLE FOR FORM 13F eFFECTOR Therapeutics Inc COM 28202V108 1842669 4309329 SH SOLE 4309329 0 0 NGM Biopharmaceuticals Inc COM 62921N105 91046410 18136735 SH SOLE 18136735 0 0 ORIC Pharmaceuticals Inc. COM 68622P109 21016586 3568181 SH SOLE 3568181 0 0 RAPT Therapeutics Inc COM 75382E109 53076296 2680621 SH SOLE 2680621 0 0 Revolution Medicines Inc COM 76155X100 109044149 4577840 SH SOLE 4577840 0 0 Surrozen, Inc. COM 86889P109 5478469 9414795 SH SOLE 9414795 0 0 Tenaya Therapeutics, Inc. COM 87990A106 18894583 9400290 SH SOLE 9400290 0 0